🇺🇸 FDA
Patent

US 11958903

Single-domain antibodies against LAG-3 and uses thereof

granted A61KA61K2039/505A61P

Quick answer

US patent 11958903 (Single-domain antibodies against LAG-3 and uses thereof) held by Nanjing Legend Biotech Co., Ltd expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nanjing Legend Biotech Co., Ltd
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/505, A61P, A61P35/00